Skip to main content
| News

Swiss TPH breaks ground on new headquarters

24.06.2019

The Swiss Tropical and Public Health institute (Swiss TPH) has broken ground on the new building for its headquarters in Allschwil. Set for completion by the end of 2021, the new building will offer nearly 900 workplaces, laboratory spaces as well as teaching facilities.

Visualization of the new building "Belo Horizonte" (img. Joachim Pelikan / Swiss TPH)

Swiss TPH is currently spread across seven buildings in Basel, but by the end of 2021 its employees and students will be able to work, conduct research and study under one roof, according to a press release. The new headquarters in Allschwil in the canton of Basel-Landschaft will have a floor space of 13,376 square metres and offer 725 workplaces, over 150 laboratory spaces, as well as auditoriums, classrooms and a cafeteria.

The groundbreaking ceremony for the new multifunctional building, called Belo Horizonte, was held on Friday. Guests included Monica Gschwind, President of the Government Council of Basel-Landschaft; Conradin Cramer, Member of the Government of the Canton of Basel-Stadt; Marcel Tanner, President of the R. Geigy Foundation; and Andrea Schenker-Wicki, Rector of the University of Basel.

“We are very much looking forward to our new home in Allschwil,” said Jürg Utzinger, Director of Swiss TPH. “The new building brings together work, laboratory and education spaces in a unique way that will enable us to even better fulfil our mandate to improve the health of people in the Basel region, Switzerland and worldwide.” Stefan Mörgeli, project manager for the new building, said: “We only came to Allschwil because there is the political will to build the new Switzerland Innovation Park Basel Area here.”

The new building is a part of the BaseLink area of the Bürgerspital Basel hospital. It will cost some 90 million Swiss francs, with funding provided by a credit guarantee from the cantons of Basel-Landschaft and Basel-Stadt, investment contributions from the Swiss government, Swiss TPH’s own funds, and support from the R. Geigy Foundation. Swiss TPH plans to move into the building at the end of 2021. Founded in 1943, Swiss TPH employs around 800 people.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

South Korean pharma firms show interest in the Basel Area

Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...

Read More
Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

KetoSwiss secures capital increase of 4 million dollars

KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based startup develops products to alleviate neurological...

Read More
Basel Area Business & Innovation, Invest, Life Sciences / biotech

Escientia Switzerland becomes Primopus

The Indian company Deccan Fine Chemicals is acquiring Escientia Switzerland and renaming it as Primopus AG. The new owner announces...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Novartis investing 100 million Swiss francs in new biologics center

The pharmaceutical company Novartis is investing a sum of 100 million Swiss francs in a new competence center for biologics...

Read More
1 2 3 35

Do you have a question? We'd like to hear from you.